Literature DB >> 24786387

Synthesis and biological evaluation of a unique heparin mimetic hexasaccharide for structure-activity relationship studies.

Sucharita Roy1, Ahmed El Hadri, Sebastien Richard, Fanny Denis, Kimberly Holte, Jay Duffner, Fei Yu, Zoya Galcheva-Gargova, Ishan Capila, Birgit Schultes, Maurice Petitou, Ganesh V Kaundinya.   

Abstract

To date, the structure-activity relationship studies of heparin/heparan sulfate with their diverse binding partners such as growth factors, cytokines, chemokines, and extracellular matrix proteins have been limited yet provide early insight that specific sequences contribute to this manifold biological role. This has led to an impetus for the chemical synthesis of oligosaccharide fragments of these complex polysaccharides, which can provide an effective tool for this goal. The synthesis of three heparin mimetic hexasaccharides with distinct structural patterns is described herein, and the influence of the targeted substitution on their bioactivity profiles is studied using in vitro affinity and/or inhibition toward different growth factors and proteins. Additionally, the particularly challenging synthesis of an irregular hexasaccharide is reported, which, interestingly, in spite of being considerably structurally similar with its two counterparts, displayed a unique and remarkably distinct profile in the test assays.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24786387     DOI: 10.1021/jm4016069

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Glycosidase Inhibition by Multivalent Presentation of Heparan Sulfate Saccharides on Bottlebrush Polymers.

Authors:  Eric T Sletten; Ravi S Loka; Fei Yu; Hien M Nguyen
Journal:  Biomacromolecules       Date:  2017-09-13       Impact factor: 6.988

Review 2.  The "in and out" of glucosamine 6-O-sulfation: the 6th sense of heparan sulfate.

Authors:  Rana El Masri; Amal Seffouh; Hugues Lortat-Jacob; Romain R Vivès
Journal:  Glycoconj J       Date:  2016-11-03       Impact factor: 2.916

3.  Heparan Sulfate Microarray Reveals That Heparan Sulfate-Protein Binding Exhibits Different Ligand Requirements.

Authors:  Chengli Zong; Andre Venot; Xiuru Li; Weigang Lu; Wenyuan Xiao; Jo-Setti L Wilkes; Catherina L Salanga; Tracy M Handel; Lianchun Wang; Margreet A Wolfert; Geert-Jan Boons
Journal:  J Am Chem Soc       Date:  2017-07-07       Impact factor: 15.419

4.  Design, synthesis, and evaluation of heparan sulfate mimicking glycopolymers for inhibiting heparanase activity.

Authors:  Ravi S Loka; Fei Yu; Eric T Sletten; Hien M Nguyen
Journal:  Chem Commun (Camb)       Date:  2017-08-10       Impact factor: 6.222

5.  Interactions between a Heparin Trisaccharide Library and FGF-1 Analyzed by NMR Methods.

Authors:  María José García-Jiménez; Sergio Gil-Caballero; Ángeles Canales; Jesús Jiménez-Barbero; José L de Paz; Pedro M Nieto
Journal:  Int J Mol Sci       Date:  2017-06-17       Impact factor: 5.923

6.  Making the longest sugars: a chemical synthesis of heparin-related [4] n oligosaccharides from 16-mer to 40-mer.

Authors:  Steen U Hansen; Gavin J Miller; Matthew J Cliff; Gordon C Jayson; John M Gardiner
Journal:  Chem Sci       Date:  2015-07-24       Impact factor: 9.825

Review 7.  Heparan Sulfate Mimetics in Cancer Therapy: The Challenge to Define Structural Determinants and the Relevance of Targets for Optimal Activity.

Authors:  Cinzia Lanzi; Giuliana Cassinelli
Journal:  Molecules       Date:  2018-11-08       Impact factor: 4.411

8.  The Use of Myelinating Cultures as a Screen of Glycomolecules for CNS Repair.

Authors:  George A McCanney; Susan L Lindsay; Michael A McGrath; Hugh J Willison; Claire Moss; Charles Bavington; Susan C Barnett
Journal:  Biology (Basel)       Date:  2019-06-28

Review 9.  The Role of Heparanase and Sulfatases in the Modification of Heparan Sulfate Proteoglycans within the Tumor Microenvironment and Opportunities for Novel Cancer Therapeutics.

Authors:  Edward Hammond; Ashwani Khurana; Viji Shridhar; Keith Dredge
Journal:  Front Oncol       Date:  2014-07-24       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.